| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ADP transmembrane transporter activity | 3.83e-07 | 11 | 119 | 4 | GO:0015217 | |
| GeneOntologyMolecularFunction | ATP transmembrane transporter activity | 1.15e-06 | 14 | 119 | 4 | GO:0005347 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.15e-06 | 14 | 119 | 4 | GO:0008331 | |
| GeneOntologyMolecularFunction | ATP:ADP antiporter activity | 2.05e-06 | 5 | 119 | 3 | GO:0005471 | |
| GeneOntologyMolecularFunction | purine ribonucleotide transmembrane transporter activity | 9.73e-06 | 23 | 119 | 4 | GO:0005346 | |
| GeneOntologyMolecularFunction | adenine nucleotide transmembrane transporter activity | 1.62e-05 | 26 | 119 | 4 | GO:0000295 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 1.69e-05 | 9 | 119 | 3 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 1.69e-05 | 9 | 119 | 3 | GO:0099626 | |
| GeneOntologyMolecularFunction | purine nucleotide transmembrane transporter activity | 2.54e-05 | 29 | 119 | 4 | GO:0015216 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 3 activity | 3.52e-05 | 2 | 119 | 2 | GO:0033872 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC25A4 SLC25A5 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 4.17e-05 | 664 | 119 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | nucleotide transmembrane transporter activity | 4.29e-05 | 33 | 119 | 4 | GO:0015215 | |
| GeneOntologyMolecularFunction | organophosphate ester transmembrane transporter activity | 8.39e-05 | 39 | 119 | 4 | GO:0015605 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC25A4 SLC25A5 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A | 9.43e-05 | 627 | 119 | 13 | GO:0022890 |
| GeneOntologyMolecularFunction | alpha2-adrenergic receptor activity | 1.05e-04 | 3 | 119 | 2 | GO:0004938 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.61e-04 | 46 | 119 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 2.16e-04 | 343 | 119 | 9 | GO:0005261 |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC25A4 SLC25A5 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 2.69e-04 | 793 | 119 | 14 | GO:0015075 |
| GeneOntologyMolecularFunction | adenine transmembrane transporter activity | 3.48e-04 | 5 | 119 | 2 | GO:0015207 | |
| GeneOntologyMolecularFunction | fibroblast growth factor receptor activity | 3.48e-04 | 5 | 119 | 2 | GO:0005007 | |
| GeneOntologyMolecularFunction | oxidative phosphorylation uncoupler activity | 3.48e-04 | 5 | 119 | 2 | GO:0017077 | |
| GeneOntologyMolecularFunction | carbohydrate derivative transmembrane transporter activity | 4.24e-04 | 59 | 119 | 4 | GO:1901505 | |
| GeneOntologyMolecularFunction | nucleobase-containing compound transmembrane transporter activity | 4.24e-04 | 59 | 119 | 4 | GO:0015932 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A | 4.72e-04 | 465 | 119 | 10 | GO:0046873 |
| GeneOntologyMolecularFunction | epinephrine binding | 5.20e-04 | 6 | 119 | 2 | GO:0051379 | |
| GeneOntologyMolecularFunction | alpha-adrenergic receptor activity | 5.20e-04 | 6 | 119 | 2 | GO:0004936 | |
| GeneOntologyMolecularFunction | bitter taste receptor activity | 5.44e-04 | 27 | 119 | 3 | GO:0033038 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC25A4 SLC25A5 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A | 5.91e-04 | 758 | 119 | 13 | GO:0015318 |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity | 7.25e-04 | 7 | 119 | 2 | GO:0008467 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 7.82e-04 | 182 | 119 | 6 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 8.28e-04 | 184 | 119 | 6 | GO:0022832 | |
| GeneOntologyMolecularFunction | taste receptor activity | 9.88e-04 | 33 | 119 | 3 | GO:0008527 | |
| GeneOntologyMolecularFunction | RNA endonuclease activity | 1.28e-03 | 79 | 119 | 4 | GO:0004521 | |
| GeneOntologyMolecularFunction | purine nucleobase transmembrane transporter activity | 1.54e-03 | 10 | 119 | 2 | GO:0005345 | |
| GeneOntologyMolecularFunction | ribonuclease P RNA binding | 1.54e-03 | 10 | 119 | 2 | GO:0033204 | |
| GeneOntologyMolecularFunction | adrenergic receptor activity | 1.54e-03 | 10 | 119 | 2 | GO:0004935 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | CACNA1A CACNA1B CACNA1E SLC25A41 CACNB3 SLC25A4 SLC25A5 SLC25A6 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 1.71e-03 | 1180 | 119 | 16 | GO:0022857 |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 1.72e-03 | 459 | 119 | 9 | GO:0005216 |
| GeneOntologyMolecularFunction | nucleobase transmembrane transporter activity | 1.87e-03 | 11 | 119 | 2 | GO:0015205 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | 2.00e-03 | 296 | 119 | 7 | GO:0015291 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.18e-03 | 152 | 119 | 5 | GO:0022843 | |
| GeneOntologyMolecularFunction | ribonuclease P activity | 2.24e-03 | 12 | 119 | 2 | GO:0004526 | |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR51T1 NPBWR2 OR1D2 FZD9 ADRA2B ADRA2C P2RY2 OR4A16 OR6J1 TAS2R45 TAS2R30 TAS2R46 ADGRA3 | 2.36e-03 | 884 | 119 | 13 | GO:0004930 |
| GeneOntologyMolecularFunction | catecholamine binding | 2.63e-03 | 13 | 119 | 2 | GO:1901338 | |
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | OR51T1 NPBWR2 PECAM1 OR1D2 FZD9 LYVE1 ADRA2B ADRA2C P2RY2 OR4A16 OR6J1 FGFR1 FGFR2 TAS2R45 TAS2R30 TAS2R46 ADGRA3 | 2.73e-03 | 1353 | 119 | 17 | GO:0004888 |
| GeneOntologyMolecularFunction | sodium ion binding | 3.06e-03 | 14 | 119 | 2 | GO:0031402 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 3.52e-03 | 15 | 119 | 2 | GO:0034483 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 3.62e-03 | 171 | 119 | 5 | GO:0015081 | |
| GeneOntologyMolecularFunction | transporter activity | CACNA1A CACNA1B CACNA1E SLC25A41 CACNB3 SLC25A4 SLC25A5 SLC25A6 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 4.12e-03 | 1289 | 119 | 16 | GO:0005215 |
| GeneOntologyMolecularFunction | channel activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 4.21e-03 | 525 | 119 | 9 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | CACNA1A CACNA1B CACNA1E CACNB3 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 | 4.26e-03 | 526 | 119 | 9 | GO:0022803 |
| GeneOntologyMolecularFunction | tRNA-specific ribonuclease activity | 4.52e-03 | 17 | 119 | 2 | GO:0004549 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 4.84e-03 | 114 | 119 | 4 | GO:0004843 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.63e-03 | 119 | 119 | 4 | GO:0015294 | |
| GeneOntologyMolecularFunction | monoatomic anion:sodium symporter activity | 5.64e-03 | 19 | 119 | 2 | GO:0015373 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 6.50e-03 | 124 | 119 | 4 | GO:0101005 | |
| GeneOntologyMolecularFunction | calcium channel activity | 7.45e-03 | 129 | 119 | 4 | GO:0005262 | |
| GeneOntologyBiologicalProcess | mitochondrial ADP transmembrane transport | 4.90e-09 | 5 | 117 | 4 | GO:0140021 | |
| GeneOntologyBiologicalProcess | mitochondrial ATP transmembrane transport | 6.76e-08 | 8 | 117 | 4 | GO:1990544 | |
| GeneOntologyBiologicalProcess | ADP transport | 4.70e-07 | 12 | 117 | 4 | GO:0015866 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 1.28e-06 | 15 | 117 | 4 | GO:1901029 | |
| GeneOntologyBiologicalProcess | negative regulation of mitochondrial membrane permeability | 8.01e-06 | 23 | 117 | 4 | GO:0035795 | |
| GeneOntologyBiologicalProcess | ATP transport | 8.01e-06 | 23 | 117 | 4 | GO:0015867 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 9.57e-06 | 24 | 117 | 4 | GO:1901028 | |
| GeneOntologyBiologicalProcess | negative regulation of membrane permeability | 1.33e-05 | 26 | 117 | 4 | GO:1905709 | |
| GeneOntologyBiologicalProcess | nucleotide transmembrane transport | 2.75e-05 | 31 | 117 | 4 | GO:1901679 | |
| GeneOntologyBiologicalProcess | fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development | 3.19e-05 | 2 | 117 | 2 | GO:0035607 | |
| GeneOntologyBiologicalProcess | central nervous system neuron differentiation | 3.37e-05 | 217 | 117 | 8 | GO:0021953 | |
| GeneOntologyBiologicalProcess | forebrain generation of neurons | 3.39e-05 | 65 | 117 | 5 | GO:0021872 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization | 3.54e-05 | 33 | 117 | 4 | GO:0097345 | |
| GeneOntologyBiologicalProcess | neuromuscular junction development | 4.22e-05 | 68 | 117 | 5 | GO:0007528 | |
| GeneOntologyBiologicalProcess | pyramidal neuron development | 4.88e-05 | 13 | 117 | 3 | GO:0021860 | |
| GeneOntologyBiologicalProcess | purine-containing compound transmembrane transport | 7.68e-05 | 40 | 117 | 4 | GO:0072530 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability involved in apoptotic process | 7.68e-05 | 40 | 117 | 4 | GO:1902110 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide transport | 7.68e-05 | 40 | 117 | 4 | GO:0015868 | |
| GeneOntologyBiologicalProcess | mitochondrial outer membrane permeabilization involved in programmed cell death | 9.32e-05 | 42 | 117 | 4 | GO:1902686 | |
| GeneOntologyBiologicalProcess | adenine nucleotide transport | 9.32e-05 | 42 | 117 | 4 | GO:0051503 | |
| GeneOntologyBiologicalProcess | ventricular zone neuroblast division | 9.54e-05 | 3 | 117 | 2 | GO:0021847 | |
| GeneOntologyBiologicalProcess | orbitofrontal cortex development | 9.54e-05 | 3 | 117 | 2 | GO:0021769 | |
| GeneOntologyBiologicalProcess | purine nucleotide transport | 1.12e-04 | 44 | 117 | 4 | GO:0015865 | |
| GeneOntologyBiologicalProcess | positive regulation of mitochondrial membrane permeability | 1.22e-04 | 45 | 117 | 4 | GO:0035794 | |
| GeneOntologyBiologicalProcess | cell junction organization | CACNA1A CACNB3 CTTNBP2 RPS6 PECAM1 DOCK10 SORBS1 DCX LRIT3 OPHN1 DNAJA3 FZD9 FGFR1 FGFR2 DCLK1 CDH18 | 1.23e-04 | 974 | 117 | 16 | GO:0034330 |
| GeneOntologyBiologicalProcess | synapse organization | CACNA1A CACNB3 CTTNBP2 DOCK10 SORBS1 DCX LRIT3 OPHN1 DNAJA3 FZD9 FGFR1 FGFR2 DCLK1 | 1.39e-04 | 685 | 117 | 13 | GO:0050808 |
| GeneOntologyBiologicalProcess | pyramidal neuron differentiation | 1.61e-04 | 19 | 117 | 3 | GO:0021859 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability involved in apoptotic process | 1.71e-04 | 49 | 117 | 4 | GO:1902108 | |
| GeneOntologyBiologicalProcess | nucleotide transport | 1.85e-04 | 50 | 117 | 4 | GO:0006862 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane permeability | 1.85e-04 | 50 | 117 | 4 | GO:1905710 | |
| GeneOntologyBiologicalProcess | receptor transactivation | 1.90e-04 | 4 | 117 | 2 | GO:0035624 | |
| GeneOntologyBiologicalProcess | response to pain | 2.00e-04 | 51 | 117 | 4 | GO:0048265 | |
| GeneOntologyBiologicalProcess | skeletal muscle acetylcholine-gated channel clustering | 2.20e-04 | 21 | 117 | 3 | GO:0071340 | |
| GeneOntologyBiologicalProcess | forebrain neuron differentiation | 2.32e-04 | 53 | 117 | 4 | GO:0021879 | |
| GeneOntologyBiologicalProcess | regulation of DNA-templated DNA replication | 2.32e-04 | 53 | 117 | 4 | GO:0090329 | |
| GeneOntologyBiologicalProcess | calcium ion import | 2.40e-04 | 98 | 117 | 5 | GO:0070509 | |
| GeneOntologyBiologicalProcess | central nervous system neuron development | 2.52e-04 | 99 | 117 | 5 | GO:0021954 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | CACNA1A CACNA1B CACNA1E CACNB3 SLC25A4 SLC25A5 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A UNC80 WNK3 | 2.85e-04 | 942 | 117 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | negative regulation of catecholamine secretion | 2.90e-04 | 23 | 117 | 3 | GO:0033604 | |
| GeneOntologyBiologicalProcess | negative regulation of synaptic transmission, dopaminergic | 3.15e-04 | 5 | 117 | 2 | GO:0032227 | |
| GeneOntologyBiologicalProcess | signal release | CACNA1A CACNA1B CACNA1E INHBA RFX6 SLC6A4 ADRA2B ADRA2C P2RY2 SYT11 TMF1 FGFR1 | 3.39e-04 | 653 | 117 | 12 | GO:0023061 |
| GeneOntologyBiologicalProcess | sensory perception | OR51T1 CACNA1E CACNB3 COL11A2 LRIT3 OR1D2 OTOGL KCNQ4 OR4A16 OR6J1 SCN8A SCN10A FGFR1 TAS2R45 TAS2R30 TAS2R46 | 3.64e-04 | 1072 | 117 | 16 | GO:0007600 |
| GeneOntologyBiologicalProcess | cell junction assembly | CACNA1A RPS6 PECAM1 DOCK10 SORBS1 DCX LRIT3 OPHN1 FGFR1 DCLK1 CDH18 | 3.96e-04 | 569 | 117 | 11 | GO:0034329 |
| GeneOntologyBiologicalProcess | postsynapse organization | 4.19e-04 | 313 | 117 | 8 | GO:0099173 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | 4.22e-04 | 238 | 117 | 7 | GO:0050954 | |
| GeneOntologyBiologicalProcess | forebrain ventricular zone progenitor cell division | 4.71e-04 | 6 | 117 | 2 | GO:0021869 | |
| GeneOntologyBiologicalProcess | adenine transport | 4.71e-04 | 6 | 117 | 2 | GO:0015853 | |
| GeneOntologyBiologicalProcess | regulation of mitochondrial membrane permeability | 5.40e-04 | 66 | 117 | 4 | GO:0046902 | |
| GeneOntologyBiologicalProcess | regulation of neurotransmitter secretion | 5.66e-04 | 118 | 117 | 5 | GO:0046928 | |
| GeneOntologyBiologicalProcess | regulation of secretion | CACNA1A CACNA1B CACNA1E INHBA RFX6 SLC6A4 ADRA2B ADRA2C P2RY2 SYT11 TMF1 FGFR1 WNK3 | 6.21e-04 | 801 | 117 | 13 | GO:0051046 |
| GeneOntologyBiologicalProcess | membrane depolarization | 6.35e-04 | 121 | 117 | 5 | GO:0051899 | |
| GeneOntologyBiologicalProcess | forebrain neuron development | 6.46e-04 | 30 | 117 | 3 | GO:0021884 | |
| GeneOntologyBiologicalProcess | forebrain neuroblast division | 6.58e-04 | 7 | 117 | 2 | GO:0021873 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | CACNA1A CACNA1B CACNA1E CACNB3 SLC25A4 SLC25A5 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A WNK3 | 7.34e-04 | 922 | 117 | 14 | GO:0098662 |
| GeneOntologyBiologicalProcess | synaptic vesicle exocytosis | 7.35e-04 | 125 | 117 | 5 | GO:0016079 | |
| GeneOntologyBiologicalProcess | behavioral response to pain | 7.83e-04 | 32 | 117 | 3 | GO:0048266 | |
| GeneOntologyBiologicalProcess | monoatomic cation transport | CACNA1A CACNA1B CACNA1E CACNB3 SLC25A4 SLC25A5 SLC46A1 SLC34A3 SLC5A5 SLC6A4 KCNQ4 SCN8A SCN10A PLPP4 UNC80 WNK3 | 8.30e-04 | 1157 | 117 | 16 | GO:0006812 |
| GeneOntologyBiologicalProcess | mesodermal cell differentiation | 1.02e-03 | 35 | 117 | 3 | GO:0048333 | |
| GeneOntologyBiologicalProcess | regulation of secretion by cell | CACNA1A CACNA1B CACNA1E INHBA RFX6 SLC6A4 ADRA2B ADRA2C P2RY2 SYT11 TMF1 FGFR1 | 1.02e-03 | 740 | 117 | 12 | GO:1903530 |
| GeneOntologyCellularComponent | cation channel complex | 6.45e-05 | 235 | 120 | 8 | GO:0034703 | |
| GeneOntologyCellularComponent | glutamatergic synapse | CACNA1A CACNA1B CTTNBP2 DOCK10 DCX OPHN1 FZD9 USP6 RGS14 ADRA2C P2RY2 SCN8A SCN10A FGFR1 DCLK1 | 6.92e-05 | 817 | 120 | 15 | GO:0098978 |
| GeneOntologyCellularComponent | postsynapse | CACNA1A CACNA1E CTTNBP2 DOCK10 RPS25 SH2D5 OPHN1 SLC6A4 DNAJA3 FZD9 USP6 RGS14 ADRA2C SYT11 SCN8A FGFR1 DCLK1 | 7.13e-05 | 1018 | 120 | 17 | GO:0098794 |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 1.40e-04 | 46 | 120 | 4 | GO:0005891 | |
| GeneOntologyCellularComponent | sodium channel complex | 6.04e-04 | 29 | 120 | 3 | GO:0034706 | |
| GeneOntologyCellularComponent | mitochondrial permeability transition pore complex | 6.73e-04 | 7 | 120 | 2 | GO:0005757 | |
| GeneOntologyCellularComponent | nucleolar ribonuclease P complex | 6.73e-04 | 7 | 120 | 2 | GO:0005655 | |
| GeneOntologyCellularComponent | calcium channel complex | 8.28e-04 | 73 | 120 | 4 | GO:0034704 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 1.06e-03 | 78 | 120 | 4 | GO:0048787 | |
| GeneOntologyCellularComponent | presynaptic membrane | 1.11e-03 | 277 | 120 | 7 | GO:0042734 | |
| GeneOntologyCellularComponent | ribonuclease MRP complex | 1.15e-03 | 9 | 120 | 2 | GO:0000172 | |
| GeneOntologyCellularComponent | dendrite | CACNA1A CACNA1B CTTNBP2 RPS6 DOCK10 DCX LRIT3 OPHN1 TTLL7 RGS14 SYT11 SCN8A PREX1 | 1.31e-03 | 858 | 120 | 13 | GO:0030425 |
| GeneOntologyCellularComponent | presynaptic active zone | 1.33e-03 | 141 | 120 | 5 | GO:0048786 | |
| GeneOntologyCellularComponent | dendritic tree | CACNA1A CACNA1B CTTNBP2 RPS6 DOCK10 DCX LRIT3 OPHN1 TTLL7 RGS14 SYT11 SCN8A PREX1 | 1.34e-03 | 860 | 120 | 13 | GO:0097447 |
| GeneOntologyCellularComponent | multimeric ribonuclease P complex | 1.43e-03 | 10 | 120 | 2 | GO:0030681 | |
| GeneOntologyCellularComponent | monoatomic ion channel complex | 1.54e-03 | 378 | 120 | 8 | GO:0034702 | |
| GeneOntologyCellularComponent | somatodendritic compartment | CACNA1A CACNA1B CACNA1E CTTNBP2 RPS6 DOCK10 UPF3B DCX LRIT3 OPHN1 TTLL7 RGS14 ADRA2C SYT11 SCN8A PREX1 | 1.76e-03 | 1228 | 120 | 16 | GO:0036477 |
| GeneOntologyCellularComponent | ribonuclease P complex | 2.84e-03 | 14 | 120 | 2 | GO:0030677 | |
| GeneOntologyCellularComponent | mitochondrial nucleoid | 3.14e-03 | 51 | 120 | 3 | GO:0042645 | |
| GeneOntologyCellularComponent | nucleoid | 3.14e-03 | 51 | 120 | 3 | GO:0009295 | |
| HumanPheno | Broad proximal phalanx of the hallux | 4.07e-05 | 2 | 33 | 2 | HP:0010086 | |
| HumanPheno | Calcaneonavicular fusion | 4.07e-05 | 2 | 33 | 2 | HP:0008122 | |
| HumanPheno | 3-4 toe cutaneous syndactyly | 4.07e-05 | 2 | 33 | 2 | HP:6000648 | |
| HumanPheno | Broad middle phalanges of the toes | 4.07e-05 | 2 | 33 | 2 | HP:0010195 | |
| HumanPheno | Tracheal cartilaginous sleeve | 4.07e-05 | 2 | 33 | 2 | HP:0005347 | |
| MousePheno | abnormal channel response | 2.40e-06 | 33 | 93 | 5 | MP:0003484 | |
| MousePheno | abnormal action potential | 2.89e-05 | 133 | 93 | 7 | MP:0005402 | |
| MousePheno | premature facial suture closure | 4.38e-05 | 2 | 93 | 2 | MP:0030390 | |
| Domain | DCX | 4.85e-06 | 6 | 118 | 3 | SM00537 | |
| Domain | VDCC_a1su_IQ | 8.45e-06 | 7 | 118 | 3 | IPR014873 | |
| Domain | - | 8.45e-06 | 7 | 118 | 3 | 3.10.20.230 | |
| Domain | GPHH | 8.45e-06 | 7 | 118 | 3 | PF16905 | |
| Domain | DCX | 8.45e-06 | 7 | 118 | 3 | PF03607 | |
| Domain | GPHH_dom | 8.45e-06 | 7 | 118 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 8.45e-06 | 7 | 118 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 8.45e-06 | 7 | 118 | 3 | PF08763 | |
| Domain | DC | 1.35e-05 | 8 | 118 | 3 | PS50309 | |
| Domain | Doublecortin_dom | 1.35e-05 | 8 | 118 | 3 | IPR003533 | |
| Domain | Aden_trnslctor | 2.76e-05 | 28 | 118 | 4 | IPR002113 | |
| Domain | VDCCAlpha1 | 2.86e-05 | 10 | 118 | 3 | IPR002077 | |
| Domain | Channel_four-helix_dom | 2.98e-05 | 57 | 118 | 5 | IPR027359 | |
| Domain | - | 2.98e-05 | 57 | 118 | 5 | 1.20.120.350 | |
| Domain | Mit_carrier | 4.75e-05 | 32 | 118 | 4 | IPR002067 | |
| Domain | Mit_uncoupling | 5.19e-05 | 12 | 118 | 3 | IPR002030 | |
| Domain | Ion_trans_dom | 8.57e-05 | 114 | 118 | 6 | IPR005821 | |
| Domain | Ion_trans | 8.57e-05 | 114 | 118 | 6 | PF00520 | |
| Domain | WTX | 1.18e-04 | 3 | 118 | 2 | PF09422 | |
| Domain | Uncharacterised_FAM123 | 1.18e-04 | 3 | 118 | 2 | IPR019003 | |
| Domain | FGF_rcpt_fam | 2.36e-04 | 4 | 118 | 2 | IPR016248 | |
| Domain | DEP | 3.47e-04 | 22 | 118 | 3 | PF00610 | |
| Domain | DEP | 3.47e-04 | 22 | 118 | 3 | PS50186 | |
| Domain | DEP | 3.47e-04 | 22 | 118 | 3 | SM00049 | |
| Domain | SOLCAR | 3.49e-04 | 53 | 118 | 4 | PS50920 | |
| Domain | - | 3.49e-04 | 53 | 118 | 4 | 1.50.40.10 | |
| Domain | Mitochondrial_sb/sol_carrier | 3.49e-04 | 53 | 118 | 4 | IPR018108 | |
| Domain | Mito_carr | 3.49e-04 | 53 | 118 | 4 | PF00153 | |
| Domain | Mt_carrier_dom | 3.49e-04 | 53 | 118 | 4 | IPR023395 | |
| Domain | DEP_dom | 3.97e-04 | 23 | 118 | 3 | IPR000591 | |
| Domain | TAS2R | 5.75e-04 | 26 | 118 | 3 | PF05296 | |
| Domain | T2R | 5.75e-04 | 26 | 118 | 3 | IPR007960 | |
| Domain | USP_CS | 8.07e-04 | 66 | 118 | 4 | IPR018200 | |
| Domain | USP_1 | 1.01e-03 | 70 | 118 | 4 | PS00972 | |
| Domain | UCH | 1.06e-03 | 71 | 118 | 4 | PF00443 | |
| Domain | USP_2 | 1.06e-03 | 71 | 118 | 4 | PS00973 | |
| Domain | USP_3 | 1.12e-03 | 72 | 118 | 4 | PS50235 | |
| Domain | USP_dom | 1.12e-03 | 72 | 118 | 4 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 1.12e-03 | 72 | 118 | 4 | IPR001394 | |
| Domain | Na_channel_asu | 1.72e-03 | 10 | 118 | 2 | IPR001696 | |
| Domain | Na_trans_assoc | 1.72e-03 | 10 | 118 | 2 | IPR010526 | |
| Domain | ADR_fam | 1.72e-03 | 10 | 118 | 2 | IPR002233 | |
| Domain | Na_trans_assoc | 1.72e-03 | 10 | 118 | 2 | PF06512 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 7.35e-09 | 23 | 95 | 6 | M47666 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 6.16e-07 | 11 | 95 | 4 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 6.16e-07 | 11 | 95 | 4 | M26913 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 2.20e-05 | 25 | 95 | 4 | M47948 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01006 | 3.44e-05 | 10 | 95 | 3 | M47694 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 4.70e-05 | 11 | 95 | 3 | M47958 | |
| Pathway | REACTOME_TRANSPORT_OF_NUCLEOSIDES_AND_FREE_PURINE_AND_PYRIMIDINE_BASES_ACROSS_THE_PLASMA_MEMBRANE | 6.24e-05 | 12 | 95 | 3 | M27728 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN1_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 8.07e-05 | 13 | 95 | 3 | M47696 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_SIGMAR1_TO_CA2_APOPTOTIC_PATHWAY | 8.07e-05 | 13 | 95 | 3 | M47751 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_SNCA_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 8.07e-05 | 13 | 95 | 3 | M47703 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_VGCC_CA2_APOPTOTIC_PATHWAY_N01004 | 1.02e-04 | 14 | 95 | 3 | M47692 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_TRANSPORT_OF_CALCIUM | 1.27e-04 | 15 | 95 | 3 | M47691 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_PSEN_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 1.56e-04 | 16 | 95 | 3 | M47695 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABBERANT_ATXN2_3_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.25e-04 | 18 | 95 | 3 | M47659 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_TRANSPORT_OF_CALCIUM | 2.25e-04 | 18 | 95 | 3 | M47761 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_TRANSPORT_OF_CALCIUM | 2.66e-04 | 19 | 95 | 3 | M47677 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 2.66e-04 | 19 | 95 | 3 | M47760 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MACHR_CA2_APOPTOTIC_PATHWAY | 3.11e-04 | 20 | 95 | 3 | M47688 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MACHR_CA2_APOPTOTIC_PATHWAY | 3.61e-04 | 21 | 95 | 3 | M47689 | |
| Pathway | WP_SYNAPTIC_VESICLE_PATHWAY | 3.80e-04 | 51 | 95 | 4 | M39457 | |
| Pathway | KEGG_TASTE_TRANSDUCTION | 4.09e-04 | 52 | 95 | 4 | M5785 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_ABETA_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.16e-04 | 22 | 95 | 3 | M47690 | |
| Pathway | KEGG_MEDICUS_REFERENCE_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.16e-04 | 22 | 95 | 3 | M47675 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_CAUSED_ABERRANT_HTT_TO_MGLUR5_CA2_APOPTOTIC_PATHWAY | 4.76e-04 | 23 | 95 | 3 | M47676 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 7.53e-04 | 61 | 95 | 4 | MM15071 | |
| Pathway | REACTOME_SENSORY_PERCEPTION_OF_TASTE | 1.16e-03 | 31 | 95 | 3 | MM15691 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 1.28e-03 | 178 | 95 | 6 | M2890 | |
| Pathway | REACTOME_INTEGRATION_OF_ENERGY_METABOLISM | 1.40e-03 | 72 | 95 | 4 | MM14631 | |
| Pathway | KEGG_MEDICUS_VARIANT_AMPLIFIED_FGFR_TO_PI3K_SIGNALING_PATHWAY | 1.57e-03 | 9 | 95 | 2 | M47397 | |
| Pathway | REACTOME_ADRENOCEPTORS | 1.57e-03 | 9 | 95 | 2 | M27302 | |
| Pathway | REACTOME_ADRENOCEPTORS | 1.57e-03 | 9 | 95 | 2 | MM15009 | |
| Pathway | REACTOME_REGULATION_OF_INSULIN_SECRETION | 1.89e-03 | 78 | 95 | 4 | M1921 | |
| Pathway | REACTOME_CLASS_C_3_METABOTROPIC_GLUTAMATE_PHEROMONE_RECEPTORS | 1.95e-03 | 37 | 95 | 3 | MM15067 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 1.95e-03 | 37 | 95 | 3 | M1029 | |
| Pathway | BIOCARTA_ETC_PATHWAY | 1.95e-03 | 10 | 95 | 2 | M15371 | |
| Pathway | WP_CELL_LINEAGE_MAP_FOR_NEURONAL_DIFFERENTIATION | 1.97e-03 | 132 | 95 | 5 | M48110 | |
| Pubmed | 7.19e-10 | 5 | 122 | 4 | 8825650 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 12450408 | ||
| Pubmed | 4.21e-08 | 3 | 122 | 3 | 38996073 | ||
| Pubmed | DNA sequences of two expressed nuclear genes for human mitochondrial ADP/ATP translocase. | 4.21e-08 | 3 | 122 | 3 | 2541251 | |
| Pubmed | Two distinct genes for ADP/ATP translocase are expressed at the mRNA level in adult human liver. | 4.21e-08 | 3 | 122 | 3 | 2829183 | |
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 4.21e-08 | 3 | 122 | 3 | 24523520 | |
| Pubmed | Alternative transcripts of Dclk1 and Dclk2 and their expression in doublecortin knockout mice. | 4.21e-08 | 3 | 122 | 3 | 18075264 | |
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 1.68e-07 | 4 | 122 | 3 | 37141091 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 33199366 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 1.68e-07 | 4 | 122 | 3 | 32616470 | |
| Pubmed | 1.68e-07 | 4 | 122 | 3 | 33396658 | ||
| Pubmed | 1.91e-07 | 15 | 122 | 4 | 20188150 | ||
| Pubmed | 1.91e-07 | 15 | 122 | 4 | 24453333 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 11296258 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 16787652 | ||
| Pubmed | 4.19e-07 | 5 | 122 | 3 | 15451373 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 6.39e-07 | 139 | 122 | 7 | 16985003 | |
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 8.36e-07 | 6 | 122 | 3 | 35324301 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 10620603 | ||
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 10328888 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 8.36e-07 | 6 | 122 | 3 | 12827191 | |
| Pubmed | 8.36e-07 | 6 | 122 | 3 | 9238069 | ||
| Pubmed | 1.46e-06 | 7 | 122 | 3 | 21370995 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.46e-06 | 7 | 122 | 3 | 35176221 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.69e-06 | 231 | 122 | 8 | 16452087 | |
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 18297725 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 27641616 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 28389228 | ||
| Pubmed | 2.33e-06 | 8 | 122 | 3 | 17881491 | ||
| Pubmed | 2.76e-06 | 28 | 122 | 4 | 19352218 | ||
| Pubmed | Mechanosensitive mTORC1 signaling maintains lymphatic valves. | 3.48e-06 | 9 | 122 | 3 | 37036444 | |
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 16382099 | ||
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 28974734 | ||
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 15229180 | ||
| Pubmed | 3.48e-06 | 9 | 122 | 3 | 16387639 | ||
| Pubmed | The doublecortin gene family and disorders of neuronal structure. | 4.96e-06 | 10 | 122 | 3 | 20236041 | |
| Pubmed | 4.96e-06 | 10 | 122 | 3 | 16869982 | ||
| Pubmed | Ion channel expression in the developing enteric nervous system. | 8.70e-06 | 37 | 122 | 4 | 25798587 | |
| Pubmed | The human TAS2R16 receptor mediates bitter taste in response to beta-glucopyranosides. | 9.05e-06 | 12 | 122 | 3 | 12379855 | |
| Pubmed | 9.05e-06 | 12 | 122 | 3 | 16120388 | ||
| Pubmed | Maternal Transient Receptor Potential Vanilloid 6 (Trpv6) Is Involved In Offspring Bone Development. | 9.70e-06 | 38 | 122 | 4 | 30786075 | |
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 16540513 | ||
| Pubmed | 1.17e-05 | 13 | 122 | 3 | 15938754 | ||
| Pubmed | Endothelial cell FGF signaling is required for injury response but not for vascular homeostasis. | 1.17e-05 | 13 | 122 | 3 | 25139991 | |
| Pubmed | FGF10/FGFR2b signaling is essential for cardiac fibroblast development and growth of the myocardium. | 1.17e-05 | 13 | 122 | 3 | 21750042 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 18583315 | ||
| Pubmed | Structural and functional diversity in the FGF receptor multigene family. | 1.22e-05 | 2 | 122 | 2 | 8417497 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22605579 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21538817 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15610184 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 1.22e-05 | 2 | 122 | 2 | 23426690 | |
| Pubmed | Pain perception in mice lacking the beta3 subunit of voltage-activated calcium channels. | 1.22e-05 | 2 | 122 | 2 | 12161429 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 15863034 | ||
| Pubmed | Characterization of two scleroderma autoimmune antigens that copurify with human ribonuclease P. | 1.22e-05 | 2 | 122 | 2 | 9037013 | |
| Pubmed | Fibroblast Growth Factor Signaling Mediates Pulmonary Endothelial Glycocalyx Reconstitution. | 1.22e-05 | 2 | 122 | 2 | 28187268 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 1652059 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20308431 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 17284663 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 37579831 | ||
| Pubmed | Cardiovascular regulation in mice lacking alpha2-adrenergic receptor subtypes b and c. | 1.22e-05 | 2 | 122 | 2 | 8670422 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 37373335 | ||
| Pubmed | Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancer. | 1.22e-05 | 2 | 122 | 2 | 30914635 | |
| Pubmed | Developmental expression of two murine fibroblast growth factor receptors, flg and bek. | 1.22e-05 | 2 | 122 | 2 | 1667382 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 20694145 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 19342486 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26842067 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 22475533 | ||
| Pubmed | The ADP/ATP translocator is not essential for the mitochondrial permeability transition pore. | 1.22e-05 | 2 | 122 | 2 | 14749836 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23376566 | ||
| Pubmed | KIAA0369, doublecortin-like kinase, is expressed during brain development. | 1.22e-05 | 2 | 122 | 2 | 10533048 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 25171497 | ||
| Pubmed | Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis. | 1.22e-05 | 2 | 122 | 2 | 25926357 | |
| Pubmed | Immunolocalization of fibroblast growth factor receptors 1 and 2 in mouse palate development. | 1.22e-05 | 2 | 122 | 2 | 11391199 | |
| Pubmed | The DCX-domain tandems of doublecortin and doublecortin-like kinase. | 1.22e-05 | 2 | 122 | 2 | 12692530 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 36382369 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16188231 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 38155373 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9499422 | ||
| Pubmed | Doublecortin (Dcx) family proteins regulate filamentous actin structure in developing neurons. | 1.22e-05 | 2 | 122 | 2 | 23303949 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21527526 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 21854681 | ||
| Pubmed | Characterization of the regulatory regions of murine alpha 2C2 adrenoceptor subtype gene. | 1.22e-05 | 2 | 122 | 2 | 8762185 | |
| Pubmed | The doublecortin and doublecortin-like kinase 1 genes cooperate in murine hippocampal development. | 1.22e-05 | 2 | 122 | 2 | 16766710 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 23348274 | ||
| Pubmed | P-Rex2 regulates Purkinje cell dendrite morphology and motor coordination. | 1.22e-05 | 2 | 122 | 2 | 18334636 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 37212424 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 9747029 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 12112115 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 1315677 | ||
| Pubmed | Human microcephaly protein RTTN interacts with STIL and is required to build full-length centrioles. | 1.22e-05 | 2 | 122 | 2 | 28811500 | |
| Pubmed | FGFR1 down-regulation in differentiating human brain and spinal cord neurospheres. | 1.22e-05 | 2 | 122 | 2 | 15618886 | |
| Pubmed | Leucine-rich repeat, immunoglobulin-like and transmembrane domain 3 (LRIT3) is a modulator of FGFR1. | 1.22e-05 | 2 | 122 | 2 | 22673519 | |
| Pubmed | Role of adenine nucleotide translocator 1 in mtDNA maintenance. | 1.22e-05 | 2 | 122 | 2 | 10926541 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16508141 | ||
| Pubmed | Doublecortin-like kinase enhances dendritic remodelling and negatively regulates synapse maturation. | 1.22e-05 | 2 | 122 | 2 | 23385585 | |
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 14559809 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 28710285 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 16381801 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 24385678 | ||
| Pubmed | 1.22e-05 | 2 | 122 | 2 | 26259677 | ||
| Interaction | SCN11A interactions | 1.31e-06 | 15 | 115 | 4 | int:SCN11A | |
| Interaction | CACNA1D interactions | 9.79e-06 | 24 | 115 | 4 | int:CACNA1D | |
| GeneFamily | Calcium voltage-gated channel subunits | 6.29e-06 | 26 | 85 | 4 | 253 | |
| GeneFamily | Doublecortin superfamily | 1.18e-05 | 10 | 85 | 3 | 1369 | |
| GeneFamily | Ubiquitin specific peptidases | 1.39e-04 | 56 | 85 | 4 | 366 | |
| GeneFamily | Solute carriers | SLC25A41 SLC25A4 SLC25A5 SLC25A6 SLC46A1 SLC34A3 SLC5A5 SLC6A4 | 5.37e-04 | 395 | 85 | 8 | 752 |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 7.70e-04 | 9 | 85 | 2 | 1203 | |
| GeneFamily | Adrenoceptors | 7.70e-04 | 9 | 85 | 2 | 169 | |
| GeneFamily | Taste 2 receptors | 8.11e-04 | 39 | 85 | 3 | 1162 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 9.73e-04 | 161 | 85 | 5 | 593 | |
| GeneFamily | X-linked mental retardation|Angiotensin receptors | 1.98e-03 | 53 | 85 | 3 | 103 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_INTERM_NEUROENDOCRINE_CELL | 4.15e-06 | 268 | 120 | 9 | M45696 | |
| Coexpression | ZHONG_PFC_C3_MICROGLIA | CACNA1A CACNA1B CACNA1E CACNB3 RAP1GAP2 DPYSL4 DCX AMER2 MAST4 DCLK2 DCLK1 | 1.56e-05 | 488 | 120 | 11 | M39104 |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-AM-AM_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-08 | 168 | 121 | 8 | 52fd65024af8683db11d931f7563cbe8eb815d1c | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 3.29e-08 | 179 | 121 | 8 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | Endothelial-Endothelial-A|Endothelial / shred on cell class and cell subclass (v4) | 4.43e-08 | 122 | 121 | 7 | 65849d1296934d5765afd006cbb6739383b9f49f | |
| ToppCell | 18-Distal-Mesenchymal-Cartilage|Distal / Age, Tissue, Lineage and Cell class | 5.90e-08 | 193 | 121 | 8 | 52f3d1bb8d8ca91ba12439d46392f377928ff8f8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.47e-08 | 199 | 121 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Adenocarcinoma_Mixed_Subtype-2|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.60e-07 | 158 | 121 | 7 | 9dea15b28f64206bac0e785df6f36a2cc9010ac7 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.79e-07 | 167 | 121 | 7 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neurons_B-Branch_B2_(eMN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.28e-07 | 180 | 121 | 7 | 368ff7fcfd21ad248f96a83a8b191040ba7d8670 | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-5|TCGA-Breast / Sample_Type by Project: Shred V9 | 6.76e-07 | 182 | 121 | 7 | 9e48d5b634603bc7a8d29290202a311457678328 | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-07 | 185 | 121 | 7 | efc5d564f8793c751ba640aef60f761e4b081d3f | |
| ToppCell | primary_auditory_cortex_(A1C)-Non-neuronal-Macroglial-Oligo-OPC|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 7.54e-07 | 185 | 121 | 7 | fba2dc46cd98ab9c78e788959c2121aa10d148b2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.11e-07 | 187 | 121 | 7 | 73931a5ea73799095daff100b5f18853c57c74dc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mono-Mono_anti-infl-A|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.02e-07 | 190 | 121 | 7 | 63018acb7ad80415e861643162abdc2e55968ee4 | |
| ToppCell | 15-Airway-Mesenchymal-Cartilage|Airway / Age, Tissue, Lineage and Cell class | 1.07e-06 | 195 | 121 | 7 | 414f60bc0f0d0ecb5137bcd617fae91f0c15038a | |
| ToppCell | Tracheal-10x3prime_v2-Epithelial-Epi_airway_neuro-secretory|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-06 | 197 | 121 | 7 | ff4df77117165b6b25315e29b0722cc136eba607 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_alveolar-Macro_alv_dividing|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-06 | 197 | 121 | 7 | d669d90c3f9e98b41bcbc49dbdc5698e0b42597c | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.62e-06 | 163 | 121 | 6 | 3efbbdc9cb2613bb76d8c2f07cd4ec1a2c51a622 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.82e-06 | 164 | 121 | 6 | be49af6335f2505065cde2cb9800e4a5516811b1 | |
| ToppCell | moderate-Myeloid-Mast_cell|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.24e-06 | 166 | 121 | 6 | c3835b424c63bf11a4e2c47635dc3787fc4a637a | |
| ToppCell | E17.5-Mesenchymal-mesenchymal_fibroblast-tracheal_fibroblast|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 6.91e-06 | 169 | 121 | 6 | 58e22f9119240664515fe91ca53812611a8f17d6 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.91e-06 | 169 | 121 | 6 | b6b5bb6408c1305a00719e1b88a5e1202081faf3 | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Pulmonary_NE_precursor|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 7.15e-06 | 170 | 121 | 6 | 98d13dbd76a826e47d55553f9d11f71c043b573e | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)|Adult / Lineage, Cell type, age group and donor | 8.43e-06 | 175 | 121 | 6 | 4db1a3c284488b3f6de7568363f176d74e2a4587 | |
| ToppCell | Adult-Epithelial-lung_neuroendocrine_cell_(PNEC)-D231|Adult / Lineage, Cell type, age group and donor | 8.43e-06 | 175 | 121 | 6 | 8d9f44a2633b71fb4d2b4a7d9530f954e07c4a18 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.05e-05 | 182 | 121 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.09e-05 | 183 | 121 | 6 | 0e468daed40c28dca64a9bc2867b46e4ea9d1a06 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Endothelial-endocardial_endothelial_cells|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.09e-05 | 183 | 121 | 6 | b0b5a41f1a40f9c946d0dc8b67eaccdd9f9b73a5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.12e-05 | 184 | 121 | 6 | 282118f8221fa383ffb81dfb5798a0b7f065f911 | |
| ToppCell | wk_08-11-Epithelial-PNS-PCP4+_neuron|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.12e-05 | 184 | 121 | 6 | eac2a9089913f33a961ba11519b53645790f2056 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 1.12e-05 | 184 | 121 | 6 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Degenerative_Cortical_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-05 | 185 | 121 | 6 | 9438097e94219c1db922b8507e3a29106d32a923 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.19e-05 | 186 | 121 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-05 | 188 | 121 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | 21-Trachea-Epithelial-Neuroendocrine|Trachea / Age, Tissue, Lineage and Cell class | 1.27e-05 | 188 | 121 | 6 | e78d4f7a5d28c77503cb041ff585d13df4c88bd2 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 190 | 121 | 6 | 40d8b3403f4e38436b961cd3a2e69826cbae3042 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell-Neuroendocrine-Neuroendocrine_L.0.7.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 190 | 121 | 6 | f6cbf6d292f488ada5f7581e1dceba6198b933d1 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Neuro-endocrine/ionocytic-lung_neuroendocrine_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.35e-05 | 190 | 121 | 6 | a9a705455019e28d655636de73b07540798f82e6 | |
| ToppCell | wk_08-11-Epithelial-Proximal_epithelial-GHRL+_neuroendocrine|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.35e-05 | 190 | 121 | 6 | b5c6f3248c0c2f648e1578457c6a729ca22bf0da | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-Artery|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.39e-05 | 191 | 121 | 6 | 4b3d5157344dbfbf4fab518611cd9fa37fac7bd9 | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-05 | 193 | 121 | 6 | 1e95ef29357969ee385b4717c0b5a497390ac260 | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-TRGV2_gdT|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.47e-05 | 193 | 121 | 6 | 544de0988510cc57744710d7cafe07aa27a0b99d | |
| ToppCell | P07-Endothelial-proliferative_endothelial_cell-proliferative_endothelial_cell|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.47e-05 | 193 | 121 | 6 | 0f21fb8b35f89f4c1c8109d1a4d3d08a452f9edd | |
| ToppCell | 11.5-Distal-Epithelial-Neuroendocrine|Distal / Age, Tissue, Lineage and Cell class | 1.56e-05 | 195 | 121 | 6 | eda6ebe52c48bd6a9044886e75f584f46c2556e7 | |
| ToppCell | COPD-Endothelial-VE_Capillary_B|Endothelial / Disease state, Lineage and Cell class | 1.65e-05 | 197 | 121 | 6 | 30dbc05ea66892d2e18ff375ffa86d1db7bc4083 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.65e-05 | 197 | 121 | 6 | d8ef5cb88dd66e112cb94217b9ad5cd70164f1d0 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-05 | 197 | 121 | 6 | 33f2fe101ae5744eea3915add37e60aa398bb97f | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.65e-05 | 197 | 121 | 6 | 5e9a3932ae5147a3d73dc70f1545926a692930ed | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Neuronal-neurons_A-Branch_A2_(IPAN/IN)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.65e-05 | 197 | 121 | 6 | f7eaac1c321710a55e09ffb047a7db2baf7b7e28 | |
| ToppCell | Severe_COVID-19-Myeloid-TRAM2|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 1.65e-05 | 197 | 121 | 6 | 8a126cfe1529f3d75a806aa492743314a8a43ef9 | |
| ToppCell | BAL-Severe-Myeloid-TRAM-TRAM2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.65e-05 | 197 | 121 | 6 | 9262785807faeb32417fad7ef202405053e453e2 | |
| ToppCell | Transverse-T_cell-cycling_gd_T|Transverse / Region, Cell class and subclass | 1.70e-05 | 198 | 121 | 6 | 5131b0b7d6c4dd8872cef9f2e233f59f751b4690 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory-Neuroendocrine|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | 8f25e8dff42bad8e779ca618bdb1cb1610667962 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.70e-05 | 198 | 121 | 6 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | Transverse-(1)_T_cell-(18)_cycling_gd_T|Transverse / shred on region, Cell_type, and subtype | 1.70e-05 | 198 | 121 | 6 | 396dddf7ebad41c3a91329b6a280623c0dfdcd2f | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_neuro-secretory|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.70e-05 | 198 | 121 | 6 | e3e0aa3ef20b2370f5b133048510677aaa562dfa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 121 | 6 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Radial_glial|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 1.75e-05 | 199 | 121 | 6 | 3c9bd4d4b166788f807eaaf4f74735949031c295 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.75e-05 | 199 | 121 | 6 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | 474e6ab48f199315f3cca86b81fdf54e0461b7b8 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 1.80e-05 | 200 | 121 | 6 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | Bronchial-NucSeq-Endothelial-Endothelia_vascular-VE_alveolar_capillary_Car4_aerocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 105c67e4f5eff036013d655c8e8ac577d32dae2e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Stem_cells-Stem_cells|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 1.80e-05 | 200 | 121 | 6 | 01a29651e9bb64ef7666c6a61ec396eeb88b2816 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.80e-05 | 200 | 121 | 6 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.36e-05 | 154 | 121 | 5 | 08ffa4b6f4a1c3de037acf9d30bd14c195738ad9 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Intermediate_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 156 | 121 | 5 | 3f0b9e35d4da85c90759b930052e5b9c3cde9b15 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-intermediate_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.76e-05 | 156 | 121 | 5 | 69e6e8810d1738a66c9821910f41498931cf30cc | |
| ToppCell | facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.18e-05 | 158 | 121 | 5 | 78b48b110b777bcc4c07cd23388bee911c0231d6 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.39e-05 | 159 | 121 | 5 | 7747cef94c55144fddcd024a7495318357f1351b | |
| ToppCell | LPS-antiTNF-Endothelial-Endothelial-FOXM1|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.31e-05 | 163 | 121 | 5 | 5285318c52aa31c9b22dc2ffff078e32e408604d | |
| ToppCell | droplet-Skin-nan-18m-Epithelial-stem_cell_of_epidermis|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.81e-05 | 165 | 121 | 5 | 96f0d8bc9b13e23f757e6bb98cd7dc061a8a9564 | |
| ToppCell | droplet-Heart-4Chambers-18m-Endothelial-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.91e-05 | 86 | 121 | 4 | d20ec61a572b11641647358a546334b217c694f3 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.32e-05 | 167 | 121 | 5 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | 367C-Lymphocytic-ILC-ILC-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 9.59e-05 | 168 | 121 | 5 | 80233a13135fd159f5764336a1fe67fba237776b | |
| ToppCell | droplet-Trachea-3m-Hematologic-myeloid-granulocyte-granulocyte_l34|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 9.59e-05 | 168 | 121 | 5 | 84977db9d71e59208727885320cc18d80d064380 | |
| ToppCell | Bronchial_Biopsy-Immune-Mast_cells|Immune / Tissue, Lineage and Cell class of Lung Cells from 10X | 9.59e-05 | 168 | 121 | 5 | 45ccc0cb42d21f4853190e8e9ed9a54aefefe738 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-myeloid_leukocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-05 | 168 | 121 | 5 | ce5e92a1df3acfa5cd8d5a134e4af231dc592a13 | |
| ToppCell | droplet-Liver-Npc-18m-Myeloid-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.59e-05 | 168 | 121 | 5 | 22c89d4eb44573f6301069ec7ca7cbd0dd958403 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.86e-05 | 169 | 121 | 5 | 96a2aec9acf8a6f966973c035e5ade456cf47772 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-05 | 169 | 121 | 5 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-fibroblastic-mLTo|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.86e-05 | 169 | 121 | 5 | 559e98216720e4babf0b0941100f1b485c35b11b | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-DC-DC3-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 170 | 121 | 5 | 8276061841665e0952b3661133551ca529131dac | |
| ToppCell | BL-critical-LOC-Epithelial-Ionocyte|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.01e-04 | 170 | 121 | 5 | b465df2dac6b4e98b4ede6ad0c6347656757885c | |
| ToppCell | PND01-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.04e-04 | 171 | 121 | 5 | 6e7ade1d14a3ec4c566476aac3eb509bd2661e39 | |
| ToppCell | wk_08-11-Mesenchymal-Chondrocyte-intermediate_chondrocyte|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.07e-04 | 172 | 121 | 5 | 415d57aa6278b8c12e7a2cf9c3fa5283389fb9b0 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.07e-04 | 172 | 121 | 5 | 2b6cd84c946b1e800caba452ae70145ea285fec1 | |
| ToppCell | E15.5-Endothelial-large_vessel_endothelial_cell-endothelial_cell_of_artery|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.10e-04 | 173 | 121 | 5 | b0ff9808e38cb64a734ced498cd0546728746cd5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum_-18m-Epithelial-neuronal_stem_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-04 | 173 | 121 | 5 | f38bf7584e08d15a6e2c116b7c3551ba475a5e14 | |
| ToppCell | 5'-GW_trimst-1.5-SmallIntestine-Epithelial-neuro-epithelial-K_cells_(GIP+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.13e-04 | 174 | 121 | 5 | 3503c7dec498597f76a86dbd5e4bb2311e743bde | |
| ToppCell | (6)_Endothelial_cells-(6)_Endothelial-E|(6)_Endothelial_cells / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.13e-04 | 174 | 121 | 5 | 4a1b67ce5ea353b3f81f59fa57da07668146afca | |
| ToppCell | PND07-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_prolif|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.13e-04 | 174 | 121 | 5 | 66555c610251ea04f968c258e312d720c18e7cde | |
| ToppCell | moderate-Myeloid-Mast_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.16e-04 | 175 | 121 | 5 | bbd2971bc6d69e507f90a637834d0936c205c590 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | f7d191cde68de8f3457fa62b1df53b6d0dbe5001 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.16e-04 | 175 | 121 | 5 | 98947a226b5a2ac7091ff9d34243ea7736add973 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-18m-Endothelial-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.19e-04 | 176 | 121 | 5 | a3f27b5d7edf2d396c085efbe35305cfa0afa565 | |
| Drug | Clodronate | 1.43e-07 | 3 | 120 | 3 | DB00720 | |
| Drug | dehydroabietylamine | 5.69e-07 | 4 | 120 | 3 | ctd:C000600819 | |
| Drug | AC 110 | 5.69e-07 | 4 | 120 | 3 | CID000022860 | |
| Drug | Verapamil | 1.27e-06 | 16 | 120 | 4 | DB00661 | |
| Drug | N6-Me-dAdo | 2.68e-06 | 19 | 120 | 4 | CID000168948 | |
| Drug | 3,4-dihydroquinazoline | 2.82e-06 | 6 | 120 | 3 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 2.82e-06 | 6 | 120 | 3 | CID000133976 | |
| Drug | APMPA | 4.92e-06 | 7 | 120 | 3 | CID000512300 | |
| Drug | closantel | 4.92e-06 | 7 | 120 | 3 | ctd:C023342 | |
| Drug | Methamphetamine | 1.67e-05 | 10 | 120 | 3 | DB01577 | |
| Drug | AC1L4X2K | 1.67e-05 | 10 | 120 | 3 | CID000193824 | |
| Drug | AC1L1D9R | 1.78e-05 | 103 | 120 | 6 | CID000002254 | |
| Drug | leys | 2.28e-05 | 11 | 120 | 3 | CID000484683 | |
| Drug | CNS 1145 | 2.67e-05 | 33 | 120 | 4 | CID000190902 | |
| Drug | IHC-64 | 2.67e-05 | 33 | 120 | 4 | CID000162753 | |
| Drug | aristolactam AII | 2.75e-05 | 2 | 120 | 2 | CID000148657 | |
| Drug | alkosin | 2.75e-05 | 2 | 120 | 2 | CID005488638 | |
| Drug | norcepharadione B | 2.75e-05 | 2 | 120 | 2 | CID000189168 | |
| Drug | piperolactam A | 2.75e-05 | 2 | 120 | 2 | CID003081016 | |
| Drug | SU4984 | 2.75e-05 | 2 | 120 | 2 | DB02058 | |
| Drug | fluspirilene | 3.01e-05 | 34 | 120 | 4 | CID000003396 | |
| Drug | Ephedra | 3.03e-05 | 12 | 120 | 3 | DB01363 | |
| Drug | AC1L2VU3 | 3.03e-05 | 12 | 120 | 3 | CID000129572 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 3.89e-05 | 174 | 120 | 7 | 6085_UP | |
| Drug | bepridil | 5.56e-05 | 126 | 120 | 6 | CID000002351 | |
| Drug | trichostatin A, Streptomyces sp.; Up 200; 1uM; MCF7; HT_HG-U133A | 5.73e-05 | 185 | 120 | 7 | 5935_UP | |
| Drug | nisoldipine | 5.81e-05 | 78 | 120 | 5 | CID000004499 | |
| Drug | butamben | 6.20e-05 | 15 | 120 | 3 | CID000002482 | |
| Drug | pentasulfane | 7.61e-05 | 16 | 120 | 3 | CID000448216 | |
| Drug | oleoylcarnitine | 7.61e-05 | 16 | 120 | 3 | CID006441392 | |
| Drug | Clonidine | 8.24e-05 | 3 | 120 | 2 | DB00575 | |
| Drug | Brimonidine | 8.24e-05 | 3 | 120 | 2 | DB00484 | |
| Drug | carboxyatractyloside | 8.24e-05 | 3 | 120 | 2 | ctd:C003853 | |
| Drug | Tizanidine | 8.24e-05 | 3 | 120 | 2 | DB00697 | |
| Drug | estrone benzoate | 8.24e-05 | 3 | 120 | 2 | ctd:C024552 | |
| Drug | Gly-His-Lys acetate salt; Down 200; 1uM; PC3; HT_HG-U133A | 8.51e-05 | 197 | 120 | 7 | 6570_DN | |
| Drug | beta-hydroxypalmitoyl-CoA | 9.20e-05 | 17 | 120 | 3 | CID000440600 | |
| Drug | pranidipine | 1.30e-04 | 19 | 120 | 3 | CID006436048 | |
| Drug | Doxepin | 1.52e-04 | 20 | 120 | 3 | DB01142 | |
| Drug | agaric acid | 1.52e-04 | 20 | 120 | 3 | CID000012629 | |
| Drug | isotetrandrine | 1.64e-04 | 97 | 120 | 5 | CID000005422 | |
| Drug | Bethanidine | 1.64e-04 | 4 | 120 | 2 | DB00217 | |
| Drug | APETx2 protein, Anthopleura elegantissima | 1.64e-04 | 4 | 120 | 2 | ctd:C501880 | |
| Drug | AC1MPLOE | 1.64e-04 | 4 | 120 | 2 | CID003387244 | |
| Drug | 2-methoxyidazoxan | 1.64e-04 | 4 | 120 | 2 | ctd:C058525 | |
| Drug | 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea | 1.64e-04 | 4 | 120 | 2 | ctd:C568950 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 5.18e-08 | 3 | 111 | 3 | DOID:0111181 (implicated_via_orthology) | |
| Disease | epilepsy (implicated_via_orthology) | CACNA1A CACNA1B CACNA1E SLC25A4 SLC25A5 SLC25A6 SCN8A SCN10A | 1.99e-07 | 163 | 111 | 8 | DOID:1826 (implicated_via_orthology) |
| Disease | migraine (implicated_via_orthology) | 2.07e-07 | 4 | 111 | 3 | DOID:6364 (implicated_via_orthology) | |
| Disease | autosomal dominant progressive external ophthalmoplegia with mitochondrial DNA deletions 2 (implicated_via_orthology) | 2.07e-07 | 4 | 111 | 3 | DOID:0111517 (implicated_via_orthology) | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.79e-06 | 7 | 111 | 3 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Squamous cell carcinoma of lung | 6.29e-06 | 32 | 111 | 4 | C0149782 | |
| Disease | dyslexia (implicated_via_orthology) | 1.40e-05 | 2 | 111 | 2 | DOID:4428 (implicated_via_orthology) | |
| Disease | JACKSON-WEISS SYNDROME | 1.40e-05 | 2 | 111 | 2 | C0795998 | |
| Disease | FGFR2-related craniosynostosis | 1.40e-05 | 2 | 111 | 2 | cv:CN231480 | |
| Disease | PFEIFFER SYNDROME | 1.40e-05 | 2 | 111 | 2 | 101600 | |
| Disease | Cutis Gyrata Syndrome of Beare And Stevenson | 1.40e-05 | 2 | 111 | 2 | C1852406 | |
| Disease | Pfeiffer type acrocephalosyndactyly | 1.40e-05 | 2 | 111 | 2 | C2931888 | |
| Disease | Jackson-Weiss syndrome | 1.40e-05 | 2 | 111 | 2 | cv:C0795998 | |
| Disease | Jackson-Weiss syndrome (is_implicated_in) | 1.40e-05 | 2 | 111 | 2 | DOID:0111337 (is_implicated_in) | |
| Disease | Pfeiffer syndrome | 1.40e-05 | 2 | 111 | 2 | cv:C0220658 | |
| Disease | JACKSON-WEISS SYNDROME | 1.40e-05 | 2 | 111 | 2 | 123150 | |
| Disease | Pfeiffer syndrome (is_implicated_in) | 1.40e-05 | 2 | 111 | 2 | DOID:14705 (is_implicated_in) | |
| Disease | Pfeiffer syndrome (implicated_via_orthology) | 1.40e-05 | 2 | 111 | 2 | DOID:14705 (implicated_via_orthology) | |
| Disease | Craniofacial dysostosis type 1 | 4.20e-05 | 3 | 111 | 2 | C2931196 | |
| Disease | acrocephalosyndactylia (is_implicated_in) | 4.20e-05 | 3 | 111 | 2 | DOID:12960 (is_implicated_in) | |
| Disease | Pfeiffer Syndrome | 4.20e-05 | 3 | 111 | 2 | C0220658 | |
| Disease | Bipolar Disorder | CACNA1A CACNA1B SLC25A4 SLC6A4 ADRA2C SCN8A FGFR1 FGFR2 DCLK1 | 8.23e-05 | 477 | 111 | 9 | C0005586 |
| Disease | TWIST1-related craniosynostosis | 8.37e-05 | 4 | 111 | 2 | cv:C4551902 | |
| Disease | bone disease (implicated_via_orthology) | 1.39e-04 | 5 | 111 | 2 | DOID:0080001 (implicated_via_orthology) | |
| Disease | Mental Retardation, X-Linked | 1.76e-04 | 29 | 111 | 3 | C1136249 | |
| Disease | hypertrophic cardiomyopathy (implicated_via_orthology) | 1.76e-04 | 29 | 111 | 3 | DOID:11984 (implicated_via_orthology) | |
| Disease | Craniosynostosis syndrome | 2.91e-04 | 7 | 111 | 2 | cv:C0010278 | |
| Disease | mitochondrial metabolism disease (implicated_via_orthology) | 3.11e-04 | 35 | 111 | 3 | DOID:700 (implicated_via_orthology) | |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 6.19e-04 | 10 | 111 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 6.19e-04 | 10 | 111 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | Head and Neck Carcinoma | 6.19e-04 | 10 | 111 | 2 | C3887461 | |
| Disease | meningitis | 7.54e-04 | 11 | 111 | 2 | MONDO_0021108 | |
| Disease | Macrocephaly | 7.54e-04 | 11 | 111 | 2 | C0221355 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 9.03e-04 | 12 | 111 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | pulmonary hypertension (implicated_via_orthology) | 1.12e-03 | 54 | 111 | 3 | DOID:6432 (implicated_via_orthology) | |
| Disease | vascular dementia (biomarker_via_orthology) | 1.24e-03 | 14 | 111 | 2 | DOID:8725 (biomarker_via_orthology) | |
| Disease | Intellectual Disability | 1.54e-03 | 447 | 111 | 7 | C3714756 | |
| Disease | Tremor, Rubral | 1.63e-03 | 16 | 111 | 2 | C0750940 | |
| Disease | Ataxia, Appendicular | 1.63e-03 | 16 | 111 | 2 | C0750937 | |
| Disease | Ataxia, Motor | 1.63e-03 | 16 | 111 | 2 | C0278161 | |
| Disease | Synostotic Posterior Plagiocephaly | 1.63e-03 | 16 | 111 | 2 | C1833340 | |
| Disease | Ataxia, Sensory | 1.63e-03 | 16 | 111 | 2 | C0240991 | |
| Disease | Craniosynostosis, Type 1 | 1.63e-03 | 16 | 111 | 2 | C4551902 | |
| Disease | Acrocephaly | 1.63e-03 | 16 | 111 | 2 | C0030044 | |
| Disease | Abnormal coordination | 1.63e-03 | 16 | 111 | 2 | C0520966 | |
| Disease | Trigonocephaly | 1.63e-03 | 16 | 111 | 2 | C0265535 | |
| Disease | Scaphycephaly | 1.63e-03 | 16 | 111 | 2 | C0265534 | |
| Disease | Ataxia, Truncal | 1.63e-03 | 16 | 111 | 2 | C0427190 | |
| Disease | Drug-induced agranulocytosis | 1.63e-03 | 16 | 111 | 2 | HP_0012235 | |
| Disease | Synostotic Anterior Plagiocephaly | 1.63e-03 | 16 | 111 | 2 | C2931150 | |
| Disease | Metopic synostosis | 1.63e-03 | 16 | 111 | 2 | C1860819 | |
| Disease | Brachycephaly | 1.84e-03 | 17 | 111 | 2 | C0221356 | |
| Disease | Limb Deformities, Congenital | 1.84e-03 | 17 | 111 | 2 | C0206762 | |
| Disease | neuroimaging measurement | CTTNBP2 DPYSL4 SH2D5 SLC6A4 DNAJA3 FZD9 AMER2 MAST4 SEC14L6 FGFR2 DCLK1 | 2.34e-03 | 1069 | 111 | 11 | EFO_0004346 |
| Disease | Craniosynostosis | 2.55e-03 | 20 | 111 | 2 | C0010278 | |
| Disease | PR interval | 2.72e-03 | 495 | 111 | 7 | EFO_0004462 | |
| Disease | Primary microcephaly | 3.08e-03 | 22 | 111 | 2 | C0431350 | |
| Disease | Disproportionate short stature | 3.10e-03 | 77 | 111 | 3 | C0878659 | |
| Disease | autism spectrum disorder symptom | 3.37e-03 | 23 | 111 | 2 | EFO_0005426 | |
| Disease | Nonsyndromic Deafness | 3.57e-03 | 81 | 111 | 3 | C3711374 | |
| Disease | Cleft Palate | 3.57e-03 | 81 | 111 | 3 | C0008925 | |
| Disease | Intrahepatic Cholangiocarcinoma | 3.67e-03 | 24 | 111 | 2 | C0345905 | |
| Disease | airway responsiveness measurement | 3.67e-03 | 24 | 111 | 2 | EFO_0006897 | |
| Disease | Extrahepatic Cholangiocarcinoma | 3.67e-03 | 24 | 111 | 2 | C3805278 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TILPDKRHRVKTRVL | 201 | Q9BT88 | |
| AVAKSIPRKRISLKR | 141 | Q8N944 | |
| IKSLRVLRVLRPLKT | 1341 | O00555 | |
| VIKHKVRDLVPSSRV | 511 | Q9H0X4 | |
| ISKTAVAPIERVKLL | 21 | P12236 | |
| RTKIPVSKVLVRRVS | 636 | Q8N7J2 | |
| AAAVRKPIVLKRIVA | 51 | Q96FF9 | |
| FVKVSSPKVLQRLIR | 291 | P54284 | |
| IKTIKSLRVLRVLRP | 1251 | Q15878 | |
| SLRVLRVLRPLKTIK | 1256 | Q15878 | |
| KRRTVVTPVILTKID | 661 | Q8IWK6 | |
| LKRTPRRVKATIVAV | 161 | P18825 | |
| ISKTAVAPIERVKLL | 21 | P05141 | |
| PIVKAAKIVTDVLLR | 1226 | Q6RI45 | |
| NSKRTPRRIKCIILT | 121 | P18089 | |
| IPSRLILEIKKQLRA | 866 | Q9P1Z9 | |
| GPASVRKLALRIKVV | 381 | Q8TF44 | |
| TIKSLRVLRVLRPLK | 1246 | Q00975 | |
| IARIALKALIRGKVS | 331 | Q8N5B7 | |
| VTKLVLLRQRPAKLS | 281 | Q8TE56 | |
| VPKANRTRTKVTIRL | 161 | P08476 | |
| VLSTLSGRPVKIRKI | 21 | Q9Y2P8 | |
| VLAPRVLRAKPTVRK | 21 | Q15293 | |
| TVPLVRRVKTNVPVK | 151 | Q9UKM9 | |
| KKIPIVRRFVSSLKR | 371 | Q8HWS3 | |
| VAAKLLTVRVSVPII | 146 | Q8N130 | |
| VTARRHKPITISKRL | 581 | O60890 | |
| HKPITISKRLLRERT | 586 | O60890 | |
| KPATLRLSVIGRLKT | 801 | Q6ZRR7 | |
| IKGRKTLATPAVRRL | 166 | P11182 | |
| HKLTKRIPLRRQVTV | 416 | P21802 | |
| ITPVIRAKLSKLVRE | 371 | Q96NT5 | |
| TKLIVVVRDPVTRAI | 221 | Q9Y662 | |
| TSIPRRKKLICVTEV | 191 | Q9Y5Y7 | |
| LVTPLKSRKVIEQRC | 651 | Q6P0N0 | |
| KTVIRSIRILKFLVA | 531 | P56696 | |
| KLVTIIRSGVKPRKA | 186 | O15075 | |
| IRSGVKPRKAVRILL | 191 | O15075 | |
| VIRSGVKPRKAVRIL | 201 | Q8N568 | |
| VKVAVRIRPLLCKEA | 6 | Q86VH2 | |
| CEKLSIVRKRVSPTL | 301 | Q8NH70 | |
| VLILRTVLGIVARKK | 221 | Q8NGJ9 | |
| ASSVPRSKILTVRVI | 581 | P16284 | |
| TIVTLKKTIRISPHR | 551 | Q8IXT1 | |
| ISAVLPTAFRVAKKR | 301 | Q8TB36 | |
| VTLIVDCKKRVTRPL | 161 | P13942 | |
| KRQSLSTRKPVIIAV | 171 | P12525 | |
| TVLLRKESRKLIVQP | 661 | Q9NY33 | |
| TKLIVVVRDPVTRAI | 236 | Q9Y663 | |
| PVDTVKLRIEKTVIR | 56 | Q3SXY7 | |
| KKLITVQVVPVAARL | 411 | Q13568 | |
| PLVARKKVFRASVAL | 1141 | P28290 | |
| LGKARRKVTVLVLVV | 251 | P48146 | |
| LPRAKRKSVRTIAVV | 236 | P41231 | |
| TPLAVICVVKIIRRT | 61 | Q5VZY2 | |
| EIAKRIPIITSAKTL | 201 | P55082 | |
| IVKDLAKPRLRRATI | 351 | P13674 | |
| VTKCSLVRPKVVRSV | 131 | P25205 | |
| SKVVIRRLPPTLTKE | 51 | Q9BZI7 | |
| RPTLVLVEKTVSRIA | 746 | Q9Y2I7 | |
| PALKTIVILTLRKVA | 366 | O00144 | |
| KKSIPRITSDRLLIR | 6 | O14531 | |
| TRRPVSLAKVLKTAR | 176 | Q14781 | |
| PAEVKDLTKRIRTVL | 1651 | Q96BY6 | |
| LPRKTKDRRLVSISV | 281 | Q8WZ74 | |
| KLAKSIPLRRQVTVS | 416 | P11362 | |
| LVTIIRSGVKPRKAV | 181 | O43602 | |
| KRIVRRASLPSLSLK | 266 | Q8IX06 | |
| KQLVRKILIVIARPA | 466 | O15021 | |
| VLFITLRRSKKEPLI | 631 | Q13634 | |
| IHIKIRVPKRLTSRQ | 406 | Q96EY1 | |
| LKSLIVVRAPKLFAV | 186 | B5MCN3 | |
| TTPIHKIIVNRLARK | 1606 | Q3ZCN5 | |
| VDLTKLAVTKKRVRP | 651 | Q9BXB4 | |
| LSVKKTRDLVVRLPR | 271 | Q96E29 | |
| IIRAILRIPSVSKKY | 221 | P34982 | |
| GKSRPIKILTRLTII | 66 | P78346 | |
| LRLLLVKKPSVRSLA | 761 | Q86VV8 | |
| IKRRVKSVVLVILLG | 121 | P59541 | |
| LKRRVKSVILVVLLG | 121 | P59539 | |
| LKRRVKSVVLVILLG | 121 | P59540 | |
| PKRKIPTSRVITLKA | 221 | Q68CJ6 | |
| KPVRLSVAIPKASRV | 166 | Q9NX07 | |
| TKAPKIQRLVTPRVL | 171 | P62753 | |
| VILRSKLKTVHERIP | 196 | Q684P5 | |
| GSLRKTRPLVVKTSL | 11 | P78345 | |
| ASKIIILKRTSLPTV | 91 | Q9H0A3 | |
| AVVRLLDRSPKTVVV | 466 | Q969Y0 | |
| RILSRDKKVLVPVTT | 71 | Q9NVN3 | |
| QLALSTSLVIRKVPK | 356 | Q9NQV5 | |
| SPTLVRKKAIRSKVI | 231 | Q6ZV89 | |
| RPLRLLVATKAKEII | 696 | Q8TCU6 | |
| RPITFTLKIVNVLKR | 291 | Q7Z7L1 | |
| QTLFRRVKTLLIKAP | 16 | Q8N5S1 | |
| ILTIVRIPSASGRKK | 221 | Q8NGC5 | |
| KLITPAVVSERLKIR | 66 | P62851 | |
| RKVICIPKSITPSRI | 256 | P14550 | |
| VSKTAVAPIERVKLL | 21 | P12235 | |
| RNPKLVVTEKTIRLA | 51 | Q15468 | |
| ASPKAITKPVRRTVV | 76 | P82094 | |
| STKKLTVQRFPRILV | 446 | Q9UK80 | |
| ALVKPIRNIITAKRS | 231 | Q8N2C7 | |
| TITPPAVKRNVRKII | 266 | Q6ZWK6 | |
| IRRKLKKGAVPSVSL | 76 | Q9H5L6 | |
| RSLAPRKLVIISKGL | 376 | Q92911 | |
| TFRVLRALKTVSVIP | 216 | Q9Y5Y9 | |
| RRPLSTSEKVKVRTL | 696 | Q5XPI4 | |
| LRARSISAVKIIPVK | 31 | Q9BX66 | |
| TRRILIPFSQRKLTK | 421 | Q70CQ1 | |
| KSLLRILVTPKGRAA | 626 | Q6ZS81 | |
| LVIRAKISSEKVVPA | 46 | Q99727 | |
| TFRVLRALKTISVIP | 221 | Q9UQD0 | |
| LRVLVSTKPRETVKI | 666 | Q70Z35 | |
| ALERVVRISAKPTKR | 381 | O43566 | |
| SRPPLSRLVVVKKAK | 256 | Q9BW85 | |
| RITVKRTCIKSLPSV | 1866 | Q9UPU5 | |
| ARALVNPVKLRKLVI | 3576 | Q7Z7G8 | |
| LKSSLIRKPRIVSRG | 166 | B4DU55 | |
| PFETVISVKAKIRRL | 46 | Q86XD8 | |
| RGKSLRVQKIRPSIL | 251 | Q9H3M7 | |
| RLIITPGTFKERIIK | 596 | P31645 | |
| TQKSVAPLKLRRTIA | 596 | P35125 | |
| KVLDIVKTSIRTVLP | 736 | Q6ZT98 | |
| VASPRIISLAKPKVR | 331 | Q9P2T0 | |
| LEKTRKLVLRPALAV | 156 | Q6ZT21 | |
| AKSIRDRVTPIKKTR | 481 | Q9BYP7 |